This article reviews the statistical theory underlying the edgeR software package for differential expression of RNA-seq data. Negative binomial models are used to capture the quadratic mean-variance relationship that can be observed in RNA-seq data. Conditional likelihood methods are used to avoid bias when estimating the level of variation. Empirical Bayes methods are used to allow gene-specific variation estimates even when the number of replicate samples is very small. Generalized linear models are used to accommodate arbitrarily complex designs. A key feature of the edgeR package is the use of weighted likelihood methods to implement a flexible empirical Bayes approach in the absence of easily tractable sampling distributions. The methodology is implemented in flexible software that is easy to use even for users who are not professional statisticians or bioinformaticians. The software is part of the Bioconductor project.
Introduction
With the dramatic drop in sequencing costs provided by the Next Generation sequencing technologies in past few years, RNA-seq has now supplanted microarrays as the technology of choice for genome level expression profiling of RNA samples [17, 28, 24] . RNA-seq data is typically summarized by counting the number of sequence reads that map to genomic features of interest [10] . In this article we will assume that the aim is to conduct a gene-level analysis, but similar analyses could be done for exons or exon-junctions or other genomic constructs. One very common problem is to use the read counts to identify genes that are differentially expressed between experimental conditions. This article reviews the statistical theory underlying the edgeR software package [20] for differential expression analysis of RNA-seq data. Rigorous and statistically powerful analysis of RNA-seq data requires careful attention to a number of issues. The read counts are discrete integers that show strong mean-variance relationships. Different genes show different levels of variability, but the number of replicate samples from which variability is estimated can be very small indeed. Meanwhile, experiments may involve complex experimental designs with multiple treatment factors and other experimental variables.
edgeR uses negative binomial based models to capture the quadratic meanvariance relationship that can be observed in RNA-seq data, and to distinguish between biological and technical sources of variation [15] . By technical variation, we mean that associated with the sequencing technology whereas biological variation refers to changes in expression levels between experimental subjects. Information is shared between genes to estimate biological variation reliably even when the number of replicates is very small [23] . Conditional likelihood methods are used to avoid bias when estimating the level of variation [23, 15] . Empirical Bayes methods are used to allow gene-specific variation estimates while borrowing information between genes [22, 15] . A key feature of the edgeR package is the use of weighted likelihood methods to implement a flexible empirical Bayes approach in the absence of easily tractable sampling distributions. Finally, generalized linear models are used to accommodate arbitrarily complex designs, and the conditional likelihood and empirical Bayes procedures are generalized to work in this context [15] .
This article also describes some recent additions to the package, not previously described in published form. In particular, loess-style weighting is used to improved the weighted likelihood approach, and an analogy with quasi-likelihood [11] is used to estimate the optimal weight to be given to the empirical Bayes prior. The article includes a fully worked case study.
The edgeR package is part of the Bioconductor project [7] . Some advanced numerical algorithms are used to ensure reliable convergence of the iterative algorithms, and some of the core code has been implemented in C++ for speed and numerical stability. The package can be installed from the Bioconductor website http://www.bioconductor.org. In a typical RNA-seq experiment, purified RNA is converted to cDNA and sequenced on one of the high-throughput platforms. Millions of short 'read' sequences ranging from 25 to 300 base pairs in length are generated from one (single-end) or both (paired-end) ends of the cDNA fragments. These sequences must be aligned (or mapped ) to a reference genome or transcriptome. Summarization is then performed by counting the number of reads mapped to known genomic features such as genes or exons. For simplicity, we will refer to these features as 'genes' although any genomic interval can be used. This results in a table of read counts for tens of thousands of genes across a number of samples. These samples are associated with a variety of treatment conditions that we want to compare. Table 1 shows an example of the matrix of read counts for a very simple RNAseq experiment. The dataset consists of two groups (wild-type and mutant), each of which contains samples from two mice, i.e., two biological replicates. After sequencing, reads for each sample are mapped to the mouse genome and summarized into gene-level counts. The final RNA-seq expression profile is represented by a table of read counts for tens of thousands of genes in all four mice samples ( Table 1 ). The aim of this experiment is to identify differentially expressed genes between wild-type and mutant mice.
In this article, the total number of genes is denoted by G and the total number of samples is denoted by n. Hence, the table of read counts from an RNA-seq experiment is a G × n matrix of non-negative integers. We refer to the set of read counts for a sample as a library and the total number of reads in the library as the library size. For a particular gene g, let y gi denote the read count in the ith sample. The expected value of y gi given the experimental conditions and the sequencing depths is then
where N i is the library size and λ gi is the expected proportion of reads mapped to gene g in the ith sample.
In the above example, we have λ g1 = λ g2 = λ W g and λ g3 = λ g4 = λ M g where λ W g and λ M g are the expected proportion of reads mapped to gene g in the wild-type and the mutant groups, respectively. Then, the aim of the differential expression analysis is to test
for each gene g = 1, 2, ..., G.
Distinguishing Technical from Biological Variation
Two levels of variation can be distinguished in any RNA-seq experiment. First, there is the basic variability in the expression level of each gene from one biological sample to another, even when the experimental conditions have not been changed. Second, because expression levels can never be measured perfectly, there is a certain level of technical variation arising from measurement error. RNA-seq provides the possibility of disentangling these two sources of variation. Unlike microarrays, RNAseq can do this without technical replicates of the same RNA samples, because the level of technical variation from sequencing is of a predictable nature. Let π gi be the fraction of all cDNA fragments in the ith sample that originate from gene g. This can be viewed as the true unobserved expression level of gene g in individual sample i. Given π gi and the library size N i , the expected count is E(y gi |π gi ) = π gi N i . The read counts for any given gene are usually considered to follow a Poisson law under repeated sequencing runs of the same RNA sample [14] , so it is reasonable to suppose that var(y gi |π gi ) = π gi N i also. This represents technical variability associated with the sequencing technology.
Let us further suppose that π gi varies between biological replicates in such a way that the coefficient of variation (CV) remains constant for any given gene. This implies that E(π gi ) = λ gi and var(π gi ) = φ g λ 2 gi , where φ g is the squared CV and λ gi is the population mean proportion for gene g given the experimental conditions applied to sample i. The unconditional variance of y gi can then be derived as
where µ gi = λ gi N i is the population mean of y gi . Dividing both sides by µ 2 gi gives CV
The first term is the squared CV of y gi given π gi and the second is the squared CV of π gi . In other words,
This partition of CV 2 into technical and biological components was first derived by [15] . We call φ 1/2 g the biological coefficient of variation (BCV). BCV represents the coefficient of variation with which the true abundance of the gene varies between replicate RNA samples. It represents the CV that would remain between biological replicates if sequencing depth could be increased indefinitely. Note that the technical CV decreases as the size of the counts increases whereas the BCV does not. Thus, the BCV is likely to be the dominant source of uncertainty for high-count genes. Reliable estimation of the BCV is therefore crucial for realistic assessment of differential expression in RNA-seq experiments.
Generalized Linear Models Accommodate Complex Experiments
Generalized linear models (GLMs) are an extension of classical linear models to nonnormally distributed response data [18, 16] . We use GLMs to accommodate complex experimental designs with multiple explanatory factors. GLMs allow the responses to follow any linear exponential family of probability distributions, and each distribution family is characterized by it mean-variance relationship. In our case, the quadratic mean-variance relationship shown above in Equation 3 determines the negative binomial distribution family for read counts. We assume therefore that
where µ gi is the mean and φ g is now the negative binomial dispersion parameter. The assumption of negative binomial variation for y gi is equivalent to assuming that the true gene abundances π gi follow a gamma distributional law across replicate RNA samples. We use a log-linear model to represent the influence of the treatment conditions and the library sizes on the expected count sizes for any gene. Recall that µ gi is the product of the expression proportion λ gi and the library size. We suppose that λ gi can be represented by a log-linear model,
where x i is a covariate vector indicating the treatment conditions applied to sample i and β g is a vector of regression coefficients by which the covariate effects are mediated for gene g. It follows that
Gathering the covariate vectors x i into a design matrix X, the vector of linear predictors for gene g is the matrix product Xβ g . The standard GLM method would use Fisher-scoring to estimate the parameter vector β g . This is usually successful but can fail to converge for some datasets. edgeR enhances the usual Fisher-scoring algorithm with a Levenberg damping modification to ensure that the sequence of iterations converges for all genes and all datasets [15] . The modified algorithm forces a reduction in the residual deviance at each iteration. The sequence of deviances is monotonic and bounded, and so always converges unless floating point inaccuracies intervene first.
In the simple example shown in Section 2.1, the design matrix might take the form
In that case the first regression coefficient β g1 would represent the log-expression proportion in the wild-type group and the second coefficient β g2 would represent the log-fold change in expression in the mutant group relative to wild-type. In the notation of Section 2.1,
). The hypothesis of interest in this example is
and this hypothesis is tested for all genes. edgeR provides the ability to test whether any contrast of the regresssion coefficients equal to zero. Specifically, one can test the null hypothesis H 0 : c T β g = 0 where c is an arbitrary contrast vector. By default, hypotheses are tested using the usual asymptotic chisquare approximation to the likelihood ratio statistic, although edgeR also offers two more conservative F -test approximations as alternative options.
Empirical Bayes Dispersion Estimation

Overview
Accurate estimation of the dispersion parameter φ in the negative binomial model is vital for fitting GLMs and assessing differential expression. Given that an RNA-seq dataset often has a small number of samples, traditional univariate estimators of φ tend to perform poorly [23] . Maximum likelihood estimators (MLEs) in particular tend to underestimate dispersion parameters because they make no adjustment for the fact that the mean is estimated from the same data [23] .
The differential expression analysis of an RNA-seq experiment with a one-way layout was studied by Robinson and Smyth [22, 23] who proposed a quantileadjusted conditional maximum likelihood method for dispersion estimation. This approach is available in edgeR via the estimateTagwiseDisp function, but is restricted to experiments with a one-way layout, i.e., to experiments with only one experimental factor.
In this chapter, we will focus on the general case in which RNA-seq experiments may involve multiple treatment conditions and blocking variables. Dispersion estimation for complex experimental designs was studied by McCarthy et al. [15] . Their method is based on the idea of an adjusted profile likelihood proposed by Cox and Reid [4] .
Cox-Reid Adjusted Profile Likelihood
For general RNA-seq experiments with multiple factors, negative binomial dispersions are estimated using the Cox-Reid (CR) adjusted profile likelihood method [4, 15] . The CR method is based on the idea of approximate conditional likelihood which reduces to residual maximum likelihood (REML). Briefly, REML removes the effect of nuisance parameters which allows unbiased estimation of the dispersion. This accounts for all systematic sources of variation in the model.
For the purpose of estimating the dispersion, φ g is the parameter of interest whereas the regression coefficients β g and the means µ gi are nuisance parameters. One condition of the CR method is that the nuisance parameters are assumed to be orthogonal to the parameter of interest, i.e., the Fisher information matrix must be block diagonal [4] . It can be shown that orthogonality between β g and φ g follows here from the fact that φ g appears only in the variance function and not in the mean of the negative binomial GLMs [26] .
The Cox-Reid adjusted profile likelihood (APL) for φ g is the penalized loglikelihood, i.e.,
where y g is the vector of counts for gene g,β g is the estimated coefficient vector, is the log-likelihood function and I g is the Fisher information of β g evaluated atβ g and φ g . Note that theβ g is the MLE of β g given φ g . Thus,β g is also a function of φ g . This means that the log-likelihood can be considered as a profile likelihood p which depends only on φ g , i.e., (φ g ; y g ,β g ) = p (φ g ; y g ). Similarly, the adjustment term I g can be treated as a function of φ g . Maximization of APL g (φ g ) can then be used to obtain an estimate for φ g .
Weighted Likelihood Empirical Bayes
The empirical Bayes method is one of the most powerful tools in data analysis. The aim is to estimate the prior distribution from the data and then apply the standard Bayesian approach to obtain posterior estimates. Empirical Bayes estima-tion has been shown to outperform classical maximum likelihood estimates for high dimensional problems [6, 5, 25] .
The cost of RNA-seq experiments often limits RNA-seq studies to only a small number of replicate libraries. This makes it difficult to obtain reliable dispersion estimates. The situation is further complicated by the fact that different genes may have different dispersions. For microarray data, this problem has been solved by applying an empirical Bayes strategy [25] where information is shared across genes or probes to stabilize the gene-wise variance estimates. It is tempting to apply a similar approach to RNA-seq data. Unfortunately, the direct empirical Bayes approach to stabilize the dispersion estimates is not applicable in the case of RNAseq data since there is no conjugate prior distribution for the negative binomial dispersion φ.
One way to approximate the empirical Bayes strategy is to use a weighted likelihood. It can be shown that an empirical Bayes estimator is equivalent to an estimate obtained by maximizing a weighted likelihood function on a set of observations [27, 3] . This result provides an opportunity to implement an approximation of the empirical Bayes method for RNA-seq data.
Common Dispersion The simplest approach of sharing information between genes is to assume that all genes share a same dispersion value φ, which is called the common dispersion [23, 15] . It can be estimated by maximizing the common APL, which is defined as
where G is the total number of genes in the dataset. The common APL can be considered as a special weighted likelihood in which the likelihoods for each gene have equal weights. Hence, all genes contribute equally to the estimation of this common dispersion. A common dispersion can be estimated in edgeR via the estimateGLMCommonDisp function.
Trended Dispersion The common dispersion approach is almost certainly too simple. It is far more likely that some genes have larger or smaller dispersion values than other genes. It has been found in many RNA-seq datasets that genes with lower expression level tend to have larger dispersions, and vice versa. Hence, it is reasonable to assume that the dispersion values depend on the gene-wise expression levels and can be modelled by a mean-dispersion trend [1] . In edgeR, the dispersion values obtained from the mean-dispersion trend are referred to as the trended dispersion, and in principle genes with the same expression level (or the same mean) should have the same trended dispersion.
The trended dispersion can also be estimated by the weighted likelihood approach. Given an RNA-seq dataset, the overall expression level of each gene is calculated as an average across all samples and expressed as an average log countper-million (logCPM) using the aveLogCPM function. This average is computed by a simple GLM, taking into account the common dispersion and the library sizes. Then, all the genes are sorted according to their average logCPM values. For a particular gene g, a locally shared APL denoted APL Sg (φ g ) is formed by averaging the APLs of the set of genes, denoted C g , that are nearest to gene g in average logCPM. By default, the neighbourhood set C g is chosen to contain at least 25% of all genes, and the proportion is automatically increased if the total number of genes in the dataset is small. This ensures that each set C g contains enough genes (and hence sufficient information) to represent the dispersion trend locally.
A graduated weighting approach was used to account for the relevance in expression level between gene g and other genes in the set C g . The weight for the APL of gene a in C g , denoted w a , is determined by the tricube function, i.e.,
where −1 < x a < 1 represents the scaled difference in average logCPMs for genes g and a. In other words, the closer the expression levels of genes g and a are, the smaller |x a | will be, and thus the larger w a will be. This process can be repeated for all the genes in the set to obtain
as the locally shared APL for gene g. This is equivalent to fixing φ to a constant, fitting a loess curve of degree 0 through those APL a (φ) for a = 1, 2, ..., G, and using the fitted value as the final value of the locally shared APL at φ for each gene. The trended dispersion for gene g can then be estimated by maximizing APL Sg (φ g ).
Gene-specific Dispersion The trended dispersion approach would be sufficient if the true dispersions followed the mean-dispersion trend and genes with the same expression level had identical dispersion. This however is rarely true for real datasets and in practice dispersions are gene-specific. An individual dispersion therefore should be estimated for each individual gene, yet we are faced with the problem that the data from a single gene are often insufficient for reliable estimation of this dispersion. We need therefore a method that allows each gene to have its own dispersion estimate while still gaining information from the other genes. This can be achieved by an empirical Bayes approach that combines individual and shared information to obtain stable dispersion estimators. Such an approach has the effect of squeezing the genewise dispersions towards a pooled estimate, resulting in more stable inference when the number of samples is small. The problem with directly applying the empirical Bayes approach is that there is no conjugate prior for the negative binomial dispersion φ g . Thus, a weighted likelihood method has been proposed to approximate the empirical Bayes strategy Figure 1 : Genes are sorted by their expression level. The gene-specific dispersion for a particular gene g is estimated by maximizing the weighted APL, i.e., the weighted average between the gene-wise APL and the locally shared APL. The weight assigned to the locally shared likelihood is denoted by G 0 which can be interpreted as the prior number of observations. for RNA-seq count data [22, 15] . To estimate the gene-specific dispersion, the weighted APL for a particular gene g is constructed as
where APL g (φ g ) is the gene-wise APL using the information from gene g only, APL Sg (φ g ) is the locally shared APL for gene g, and G 0 is the weight assigned to the APL Sg (φ g ). The gene-specific dispersion φ g is then estimated by maximizing APL Wg (φ g ). This weighted APL approach is described in Figure 1 . In empirical Bayes terms, the locally shared APL, APL Sg (φ g ), can be interpreted as the prior distribution for φ g , and the APL g (φ g ) as the likelihood from the direct observed data. This means that the APL Wg (φ g ) can be interpreted as the posterior distribution for φ g , which is a compromise between the prior and the observation. In the weighed likelihood approach, the prior distribution for φ g can be thought of as arising from prior observations on a set of G 0 genes. Hence, the prior weight G 0 is referred to as the prior number of observations. The optimal choice for G 0 depends on the variability of the dispersions. Large values are best when the dispersions are a constant for all the genes or they closely follow the mean-dispersion trend. Smaller values are recommended when the dispersions are more variable among different genes. If G 0 = 0, no information is borrowed from other genes. This means that the gene-specific dispersion for a particular gene is purely estimated from its gene-wise APL. If G 0 is set to be infinitely large, information from that individual gene will be ignored. This means that the gene-specific dispersion will be fully determined by its locally shared APL such that the result will be the same as the trended dispersion. This information borrowing strategy can be viewed as shrinking individual dispersion estimates towards the dispersion trend (Figure 2) where the value of G 0 represents the amount of shrinkage.
Estimating Prior Weight
As mentioned previously, there is no conjugate prior for the genewise dispersion parameters. This means that there is no automatic estimation for the prior number of observations G 0 . Thus, an alterative approach must be used. To account for the fact that more samples result in more gene-wise information, we write G 0 as
where d 0 is the prior degrees of freedom and d g is the (known) residual degrees of freedom for gene g. The prior degrees of freedom represents the precision of the prior and does not depend on the total number of samples. The prior degrees of freedom can also be viewed as a measure of the consistency of the genewise dispersions. If the dispersions tend to be very gene-specific, then d 0 should be small and the prior will be vague. If the genewise dispersions tend to be consistent, i.e., close to the global trend, then d 0 should be large making the prior very informative. Once we estimate the d 0 , we can easily calculate the prior weight G 0 in the weighted likelihood to obtain the best estimator for φ g . One way to estimate the prior degrees of freedom under the GLM framework is to use a quasi-likelihood in which the uncertainty of the variance can be absorbed into an overdispersion parameter. In GLM theory, the variance function V (µ) uniquely specifies a probability distribution such as the Poisson or negative binomial distribution. The quasi-likelihood variance function can then be written as var(
where σ 2 g is a factor that we will call the quasi-dispersion parameter. Note that the quasi-likelihood function is not a log-likelihood corresponding to any actual probability distribution. Instead, it can be used to describe a function that has similar properties to a log-likelihood function.
Following [11] , we assume that the prior distribution for σ 2 g is a scaled inverse χ 2 -distribution with degrees of freedom d 0 and scaling factor s 2 0 d 0 , i.e.,
where s 2 0 can be considered as a prior mean for the quasi-dispersion. Our aim is to estimate d 0 , which represents the precision of the prior distribution for σ 2 g . Write D g for the residual deviance of the generalized linear model fitted to the read counts for gene g. The mean residual deviance
is an estimator of σ 2 g . It can be shown [3] using the saddlepoint approximation [8] that the mean deviance s 2 g follows approximately a χ 2 -distribution with degrees of freedom d g and scaling factor σ 2 g /d g , i.e.,
To make this approximation more accurate, a special calculation is required for the residual degrees of freedom d g when some of the fitted values are exactly zero. In particular, we ensure that any experimental condition for which the counts are all zero does not contribute to d g . This is because such counts will have fitted values exactly zero and will make zero contribution to the residual deviance regardless of the value of the dispersion. This calculation is a refinement on the procedure of Lund et al. [11] , and serves to make s 2 g more nearly unbiased for σ 2 g in the presence of zero counts.
The values of s 2 0 and d 0 can be estimated from the marginal distribution of s 2 g , which is scaled F -distribution,
where 
Experimental Design
We now demonstrate by way of a case study how the statistical theory in Sections 2 and 3 is applied in practice to analyze RNA-seq datasets. The case study includes the complete R code used to undertake the analysis. The data are from a study on the transcription factor IRF4 [13] . In the study, it was found that IRF4 regulated the expression of key molecules required for the aerobic glycolysis of effector T cells and was essential for the clonal expansion and maintenance of effector function of antigen-specific CD8+ T cells [13] .
One part of this study was to identify the transcriptional program regulated by IRF4 during the TCR affinity-driven population expansion of CD8+ T cells. To investigate this, T cells were harvested from Irf4 +/+ wild-type or Irf4 -/-knockout mice. The knock-out mice have a mutation which prevents the Irf4 gene from producing a viable protein. T cells were stimulated with high-affinity peptides (N4) or low-affinity peptides (V4). RNA was extracted from the cells and profiled using RNA-seq.
The study can be viewed as a 2 × 2 factorial experiment with 2-3 replicates for each combination of IRF4 and affinity peptide conditions. There are 9 RNA samples in all. As is usual for an edgeR analysis, we start with experimental information about each RNA sample contained in a data frame called targets. The data frame was created using a spreadsheet and read into R using readTargets. The aim is to detect genes that are differentially expressed (DE) between different conditions.
Mapping Reads to the Mouse Genome
The RNA samples were sequenced on an Illumina HiSeq 2000 at the Australian Genome Reseach Facility. Paired end sequencing was used, and reads were 100 bases long. This means that the first and last 100 bases of each RNA fragment were sequenced. Fragments were up to about 600 bases long in total. The raw sequence reads are available either in SRA format from the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) as series GSE49929 or in FastQ format from the European Nucleotide Archive (ENA) (http://www.ebi.ac. uk/ena) as series SRP028864. We analyse here gzipped FastQ files downloaded from ENA. There are a total of 11 samples under ENA series SRP028864, the first 9 of which are analyzed here.
We start with a data frame of file names in R: Each row corresponds to an RNA sample. The first column gives the name of the file containing the sequences of the forward strand ends of the RNA fragments. The second column gives the name of the file containing the reverse strand reads.
The paired reads were mapped to the mouse genome using the Subread aligner [9] . The aligner uses the reads from both ends of each fragment to locate the fragment on the genome.
> library(Rsubread) > align("mm9", readfile1=files$Forward, readfile2=files$Reverse, + "gzFASTQ", output_file=files$SAM, tieBreakQS=TRUE)
This code also uses an index ("mm9") of the mouse genome. The index was created from the NCBI37/mm9 (July 2007) build of the mouse genome using the buildindex command of the subread package [9] . The mm9 index file can be downloaded from the Subread website http://subread.sourceforge.net. The number of reads (forward and reverse) varies from 12 million to 19 million for each sample. For this dataset, the proportion of reads successfully mapped to the genome was more than 99% for all samples. This suggests good quality RNA samples and successful alignment: 
Fragment Counts for Each Gene
Now we compute a table of genewise counts. This is a two-step process. First the mapped reads are converted into mapped RNA fragments. A pair of forward and reverse reads is considered to represent an RNA fragment whenever they map to compatible nearby locations on the genome. The fragment is then assigned to a gene whenever the fragment overlaps at least one exon of the gene. This computation is done by the featureCounts function of the Rsubread package [10] :
By default, the function uses RefSeq annotation from the National Center for Biotechnology Information (NCBI) giving the start and end positions of each exon [19] . The output is a matrix of counts, one row for each NCBI Entrez Gene identifier and one column for each RNA sample.
Creating a DGEList Object
The edgeR package stores data in a simple list-based data object called a DGEList. edgeR provides a range of generic functions and methods for such data objects, but they can at the same time be manipulated like ordinary lists in R. The main components of a DGEList object are a matrix of integer counts, a data frame of sample information and an optional data frame of gene annotation.
> library(edgeR) > y <-DGEList(counts=fc$counts, group=targets$Genotype) > colnames(y) <-targets$Label
There are entries for 26310 genes and 9 samples:
Note the application of standard generic functions colnames and dim which have methods defined for DGEList objects. Many other generic functions in R that are applicable to matrices or data frames also have methods for DGEList objects. The library sizes are automatically computed by DGEList as the total number of assigned RNA fragments for each sample. The number of mapped fragments is slightly less than half the total number of mapped reads shown in Section 4.2, and the number of fragments assigned to genes is about 80% of that. Many edgeR functions will accept an ordinary matrix of counts, but a DGEList object is more convenient because it automatically collates a variety of related information. For example, subsetting the above DGEList object y by column would automatically subset both the counts and the sample information at the same time.
Filtering and Normalization
Genes with counts that are all zero or all very low are usually not of interest in a differential expression analysis for two reasons. The biological reason is that a gene must be expressed at some minimal level before it is likely to be translated into a protein or to be biologically important. The statistical reason is that very low counts provide little statistical information to distinguish between the null and alternative hypotheses. In this particular dataset, we consider a gene to be expressed at a reasonable level in a sample if its count-per-million (CPM) value is above 1, which is equivalent to having 5-7 fragments in that sample. A gene is kept in the analysis if it is sufficiently expressed (CPM > 1) in at least two samples:
The filtering rule doesn't use the experimental design information, yet will keep any gene that is expressed in both the samples for any combinations of genotype and treatment condition.
After filtering, there are 12347 genes remaining and most of the counts are greater than zero: 
Gene Annotation
The summarized counts from Rsubread include Entrez Gene IDs as rownames. The Entrez IDs link to gene-specific information from the NCBI database [12] . To get more details such as gene symbol and chromosome number, we use the annotation file 'Mus musculus.gene info' obtained from the NCBI website (ftp://ftp.ncbi. nih.gov/gene/DATA/GENE_INFO/Mammalia).
> anno <-read.delim(file="Mus_musculus.gene_info", header=FALSE, skip=1)
We add selected annotation columns to the DGEList object:
] > colnames(y$genes) <-c("GeneID", "Symbol", "Chr") > head(y$genes) GeneID Symbol Chr  7060  27395 Mrpl15  1  4165  18777 Lypla1  1  5899  21399  Tcea1  1  24191 108664 Atp6v1h  1  625 12421 Rb1cc1 1
Data Exploration
A multiple dimensional scaling (MDS) plot can be used to check the dissimilarities among the samples:
plotMDS is a generic function defined in the limma package with a method defined for DGEList objects. The distance between each pair of samples is calculated as the leading fold change, defined as the root-mean-square of the largest 500 log 2 -fold changes between that pair of samples. Samples are well separated by the genotype condition (i.e., IRF4 wild-type and knock-out) in the first dimension. A separation by the affinity peptide level (N4 and V4) is also observed in the second dimension. All the replicates are close to each other except for the ones in the IRF4 knock-out (KO) with high-affinity peptides (N4).
The Design Matrix
We create a design matrix to capture all the experimental information. In this case study, the IRF4 genotype conditions (KO and WT) and the affinity peptide levels (N4 and V4) divide the data into four separate groups. The design matrix can be constructed using the model.matrix function as described below.
> fac <-paste(targets$Genotype, targets$Treatment, sep=".") > fac <-factor(fac) > design <-model.matrix(~0+fac) > colnames(design) <-levels(fac) > design KO.N4 KO.V4 WT.N4 WT. We use this simple group-mean parametrization instead of a classic factorial model because it allows contrasts between the groups to be extracted in a simple and transparent way.
Estimating Dispersions
Now we can proceed to dispersion estimation. The estimateDisp function implements the weighted likelihood empirical Bayes strategy described earlier in this chapter. It takes the data object and the design matrix as arguments, and inserts the common, trended and genewise (tagwise) dispersions into the data object:
> y <-estimateDisp(y, design)
The common dispersion of 0.051 is equivalent to a overall BCV of 23%: The estimated prior degrees of freedom for this dataset is 6.9:
> y$prior.df [1] 6.9
This can be compared to the residual degrees of freedom d g , which is equal to 5 for most genes in this dataset. The prior degrees of freedom is slightly greater than the residual degrees of freedom, meaning that slightly more weight is being given to the global trend rather than the individual gene when estimating each genewise dispersion. The BCV plot shows the common, trended and genewise dispersions as a function of average logCPM.
> plotBCV(y)
Recall that the BCV is the square root of the dispersion. Most of the gene-specific BCVs cluster around the BCV trend, which decreases and then asymptotes to a constant value as the gene expression level increases.
Detecting Differentially Expressed Genes
In this study, one particular comparison of interest is between IRF4 wild-type (WT) cells stimulated with high-affinity peptide (N4) and WT cells stimulated with lowaffinity peptide (V4). To find genes that are DE for this comparison, the first step is to fit genewise negative binomial GLMs using the gene-specific dispersions estimated above:
> fit <-glmFit(y, design) Then likelihood ratio statistics are computed for the comparison of interest: > lrt <-glmLRT(fit, contrast=c(0,0,1,-1))
Here the contrast argument specifies that the third and fourth groups are to be compared.
The topTags function collates results for the most significant genes: Local false discovery rates (FDR) are calculated using the Benjamini-Hochberg (BH) method [2] . By default, topTags displays the top 10 genes, but can be asked to select any number. By ranking all genes, we can see that there are 1181 genes detected as DE at an FDR cutoff of 1%:
> tp <-topTags(lrt, n=Inf) > sum(tp$ The axes of the plot correspond to the logCPM and logFC columns of the results table.
Session Information
The following output shows the R session and package versions used for this case study:
> sessionInfo() R version 3.0.2 (2013-09-25) Platform: i386-w64-mingw32/i386 (32-bit) 
